Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis

Rhinology

Volumn 41, Issue 3, 2003, Pages 167-174

  Watanabe, H ^a   Foo, T H ^a   Djazaeri, B ^a   Duncombe, P ^b   Mackay, I S ^a   Durham, Stephen R ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b BRI International Ltd   (United Kingdom)

Author keywords

Acoustic rhinometry; Oxymetazoline; Rhinitis medicamentosa

Indexed keywords

NOSE SPRAY; OXYMETAZOLINE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; EPISTAXIS; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; NOSE AIRWAY RESISTANCE; NOSE CONGESTION; NOSE OBSTRUCTION; OUTCOMES RESEARCH; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; REBOUND; RHINITIS; RHINOMANOMETRY; RHINOMETRY; SIDE EFFECT; SYMPTOM; TACHYPHYLAXIS;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; DIAGNOSTIC TECHNIQUES, RESPIRATORY SYSTEM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL DECONGESTANTS; NASAL OBSTRUCTION; OXYMETAZOLINE; TACHYPHYLAXIS; TREATMENT OUTCOME;

EID: 0141990736     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Åkerlund A, Bende M (1991) Sustained use of xylometazoline nose drops aggravates vasomotor rhinitis. Am J Rhinol 5: 157-160.
2. Batts A, Marriott C, Martin G, Bond S (1989) The effect of some preservatives used in nasal preparations on mucociliary clearance. J Pharm Pharmacol 41: 156-159.
3. Braat JPM, Ainge G, Bowles JAK, Richards DH, Van Riessen D, Visser WJ, Rijntjes E (1995) The lack of effect of benzalkonium chloride on the cilia of the nasal mucosa in patients with perennial allergic rhinitis: A combined functional, light, scanning and transmission electron microscopy study. Clin Exp Allergy 25: 957-965
4. Cauna N, Cauna D (1974) Association of nerve fibers and plasma cells in abnormal human nasal respiratory mucosa. Otol 83: 347-359.
5. Clement PAR (1984) Committee report on the standardisation of rhinomanometry. Rhinology 22: 151-155.
6. Dallimore NS, Eccles R (1977) Changes in human nasal resistance associated with exercise, hyperventilation and rebreathing. Acta Otolaryngologica (Stockholm) 84: 416-421.
7. Eccles R, Wilson H (1974) The autonomic innervation of the blood vessels of the cat. J Physiol 238: 549-560.
8. Edgington ES (1980) Randomisation Tests. Marcel Dekker NY.
9. Elwany SS, Stephanos WM (1983) Rhinitis medicamentosa. An experimental histopathological and histochemical study. Orl 45: 187-194.
10. Feinberg S, Friedlaner S (1945) Nasal congestion from frequent use of privine HCl. JAMA 128:1095-1096.
11. Fox N (1931) Chronic effect of epinephrine and ephedrine on the nasal mucosa. Arch Otol 13: 73-76.
12. Graf P, Juto JE (1994) Decongestion effect and rebound swelling of the nasal mucosa during 4 week use of oxymetazoline. J Otorhinolaryngology 56: 157-160.
13. Graf P, Juto JE (1995a) Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling. Rhinology 233: 14-17.
14. Graf P, Hallen H, Juto JE (1995b) Four-week use of oxymetazoline nasal spray (Nezeril) once daily at night induces rebound swelling and nasal hyperreactivity. Acta Otolaryngologica 115: 71-75.
15. Graf P, Hallen H, Juto JE (1995c) Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers. Clin Exp Allergy 25: 395-400.
16. Graf P, Hallen H (1996) Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays. Laryngoscope 106: 605-609.
17. Hallen H, Graf P (1995) Benzalkonium chloride in nasal decongestive spray has a long-lasting adverse effect on the nasal mucosa of healthy volunteers. Clin Exp Allergy 25: 401-405.
18. Hirschberg A (2002) Rhinomonometry: An update. ORL J Otorhinolaryngol Relat Spec 64: 263-267.
19. Kully B (1945) Use and abuse of vasoconstrictor medications. JAMA 127: 307-310.
20. Lake C (1946) Rhinitis medicamentosa. Staff Mayo Clinic 21: 367-371.
21. Lund VL, Aaronson D, Bousquet J, Dahl R, Davies RJ, Durham SR, VanWijk RG, Holmberg K, Juniper E, Mackay IS, Malm L, Mygind N, Okuda M, Ortolani C, Schanker HM, Spector SL, Van Cauwenberge P, Wayoff MR (1994) International consensus report on the diagnosis and management of rhinitis. Allergy European Journal of Allergy and Clinical Immunology 49: 1-34
22. Mabry RL (1982) Rhinitis medicamentosa: The forgotten factor in nasal obstruction. South Med J 75: 817-819.
23. Malm L (1973) Stimulation of sympathetic nerve fibres to the nose in cats. Acta Otolaryngol (Stockh) 75: 519-526.
24. Miszkiel K, Beasley R, Holgate S (1988) The influence of ipratropium bromide and sodium cromoglycate on benzalkonium chloride-induced bronchoconstriction in asthma. Br J Clin Pharmacol 26: 295-301.
25. Numminen J, Ahtinen M 3rd, Huhtala H, Laranne J, Rautiainen M (2002) Correlation between rhinometric measurement methods in healthy young adults. Am J Rhinol 16: 203-208.
26. Petruson B (1981) Treatment with zylometazoline (Otrivin) nose drops over a six week period. Rhinology 19: 167-172.
27. Proctor DF, Adams GK III (1968) Physiology and pharmacology of nasal function and mucus secretion. Blue JA Rhinitis Medicamentosa Ann All 26: 425-429.
28. Rajakulasingam K, Hamid Q, O'Brien F, Schotman E, Jose PJ, Williams TJ, Jacobson M, Barkans J, Durham SR (1997) RANTES in human allergic rhinitis: Evidence for synthesis and release after allergen challenge and relationship to tissue eosinophilia. Am J Resp Crit Care Med 155: 696-703.
29. Ryan R (1947) Vasomotor Rhinitis medicamentosa viewed histologically. Staff Mayo Clinic 22: 113-117.
30. Scadding G (1995) Rhinitis medicamentosa. Clin Exp Allergy 25: 391-394.
31. Talaat M, Belal A, Aziz T, Mandour M, Maher A (1981) Rhinitis medicamentosa: Electron microscopic study. J Laryngol Otol 95: 125-131.
32. Toohill RJ, Lehman RH, Grossman TW, Belson TP (1981) Rhinitis medicamentosa. Laryngoscope 91: 1614-1621.
33. Varney V. Varney VA, Jacobson MR, Sudderick RM, Robinson DS, Irani A-MA, Schwartz LB, Mackay IS, Kay AB , Durham SR (1992) Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils and neutrophils. Am Rev Respir Dis 145: 170-176.
34. Wang J, Bu Guo X (1991) Studies of rhinitis medicamentosa. Chin Med J 104: 60-63.
35. Wilcoxon F (1945) Individual comparisons by ranking methods. Biometrics 1: 80-83.
36. Yoo JK, Seikaly H, Calhoun KH (1997) Extended use of topical nasal decongestants. Laryngoscope 107: 40-43.
37. Youlten LJF (1980) Nasal peak inspiratory flow. Allergol Immunopathol 8: 344.